The Divisions of Hematology and Oncology are committed to the delivery of exemplary clinical care, to advancing research and to training future healthcare professionals. University of California, Irvine Irvine, CA 92697, National Cancer Institute-designated comprehensive cancer center. Our physicians participate in National Cancer Institute-sponsored clinical trials featuring new drugs and the most advanced options in treatment and care. . UCI Health hematologic oncologists provide consultation and treatment for patients with many different types of cancer, These include including malignancies of the blood such as leukemia, lymphoma and myeloma, as well as solid tumor carcinomas such as colon, breast and prostate. Elizabeth Brem, MD, on Frontline Management of CLL, UCI and CSU Fullerton partner to advance cancer health disparities research with a focus on diversity and inclusion, Virus-based sensor detects bladder cancer markers in urine, 200 S. Manchester Drive, Orange, CA 92868-3217, General Medical Appointments: 714-456-8000, Biotechnology, Imaging & Drug Development, Stern Center for Cancer Clinical Trials and Research, Acknowledgement of Grant and Shared Resources, Anti-Cancer Challenge Pilot Research Projects, CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP), UCI Susan & Henry Samueli College of Health Sciences. Read More After more than a decade of work helping patients like Allen Fremont, Dr. Sai-hong Ignatius Ou has gained FDA approval for a drug treatment that targets mutations of non-small cell lung cancers. We strive to provide the best possible care, tailored for each patient's individual needs. 855-211-3729. The diseases we treat include red cell, white cell, platelet, coagulation and immune system disorders, as well as cancers of every organ system. MD , Full Professor of Medical Oncology. Fellows are expected to develop sufficient research experience by the end of the rotation to be able to prepare papers for presentation at national and regional meetings and manuscripts for publication in peer-reviewed medical journals. Learn more about our multidisciplinary cancer teams and related services, including: Located on the UCI Medical Center campus in Orange, the UCI Health Chao Family Comprehensive Cancer Center is affiliated with the UCI School of Medicine and the university's schools of basic sciences. These include state-of-the-art drugs and new biological and immunological modifiers being investigated in clinical trials. Use MyChart to schedule appointments, request prescription renewals, send messages to your care team and more. Contact. Contact Us Division of Hematology/Oncology Department of Medicine UCI School of Medicine 101 The City Drive South, Building 56, ZOT 4061 Orange, CA 92868 MAP Business office: 714-456-5153 Business fax: 714-456-2242 For clinical services and appointments, please call 714-456-8000 or fax to 714-456-7142. We emphasize a coordinated, patient-centered approach to care, with our multidisciplinary team of cancer specialists working together to ensure you and your loved ones have the best possible experience. During and after treatment, our cancer center dietitians, social workers and rehabilitation therapists work closely with you to support your recovery. Our UCI Health hematologists and hematological oncologists include: Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . Our cancer experts also are available to provide second opinions , To make an appointment, call 714-456-8000 or submit an online request , Learn about UCI Health COVID-19 safety measures (video) . Methods: This was a retrospective study of patients in the California Cancer Registry aged 18 to 79 years with recent diagnoses of anal squamous cell carcinoma. Our multidisciplinary team of world-class oncologists, surgeons, radiation oncologists, pathologists, nurses, rehabilitation therapists, pharmacists, social workers and dietitians works together seamlessly to treat cancers of all types and degrees of severity. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. Late applications may not be considered. The University of California is a major NIH funded academic institute and offers a variety of research opportunities ranging from basic molecular biology to translational clinical trials and health outcomes are available. Our researchers are at the forefront not only in treating cancer, but also in preventing it. Division of Hematology/Oncology. During the first year fellows acquire a panel of outpatients that are followed longitudinally throughout fellowship training in their continuity clinics. 2023 The Regents of the University of California. UCI Health medical oncologists are at the forefront of cancer treatment with chemotherapeutic drugs, biological agents and therapies that work with the patients immune system. We are participating in a National Cancer Institute clinical trial to determine whether COVID-19 affects therapies in cancer patients who acquire the virus. in Orange County, which means that patients with leukemia, lymphoma and other cancers no longer need to travel long distances for this life-saving treatment. Fellows receive three weeks vacation per year. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Our faculty members are subspecialty-trained, board-certified hematologists and oncologists who care for inpatients at UCI Medical Center and outpatients at Chao Family Comprehensive Cancer Center, which is the only National Cancer Institute-designated comprehensive cancer center in Orange County and one of only 50 in the nation. chak maten lm leve lyrics. All-trans-retinoic Acid (atRA) is the principal active metabolite of Vitamin A, essential for various biological processes. Department of Medicine > Division of Hematology/Oncology > Faculty Faculty Edward L. Nelson, MD Division Chief Pamela S. Becker, MD Elizabeth Brm, MD May T. Cho, MD Warren A. Chow, MD Stefan O. Ciurea, MD Director, Hematopoetic Stem Cell Transplantation and Cellular Therapy Program Paul H. Coluzzi, MD Farshid Dayyani, MD, PhD Under the direct supervision of faculty members fellows receive a thorough grounding in solid tumor oncology, general hematology, and hematologic malignancies. El Segundo, CA . UCI Health hematologic oncologists provide consultation and treatment for patients with many different types of cancer, These include including malignancies of the blood such as leukemia, lymphoma and myeloma, as well as solid tumor carcinomas such as colon, breast and prostate. Hematology-Oncology MyChart patient portal offers a convenient and secure way to manage your healthcare online. Fellows are required to undertake dedicated clinical and/or laboratory research under the supervision of a research mentor. Apply Join or sign in to find your next job. Applicants with permanent residency or J-1 visas also must provide a current certificate from the Educational Commission for Foreign Medical Graduates (ECFMG) before starting the fellowship. Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. Hematology/Oncology Fellowship (ACGME) HIV Fellowship (non-ACGME) Nephrology Fellowship (ACGME) . UCI is seeking a dynamic leader with strong credentials in clinical medicine and basic, translational, or clinical research. All rights reserved. Pediatric Hematology-Oncology (5) 41 years exp . We also are passionate about fostering these discoveries within the context of a dynamic environment that is focused on developing top-caliber physician and scientists. During the research rotation fellows receivefour weeks of intensive clinical hematology laboratory experience, which includes training in automated hematology, blood banking, flow cytometry, coagulation, transfusion medicine, special protein laboratory, and hemoglobin variant analysis. Learn more about our research and clinical trials . As the only National Cancer Institute-designated comprehensive cancer center in Orange Countyand the only one ranked among the nation's top 50 by U.S. News & World Report, we treat more patients with cancer and more complex cases than any other healthcare provider in our region. In addition, the division pays for each fellow to attend an educational conference every year and allows for educational time to attend conferences. Home. Candidates must be a U.S. citizen, permanent resident orhold a J-1 visa with ECFMG sponsorshipat the time of application submission. Research Phone: (714) 456-7511 Fax: (714) 456-6025 Email: obrien@uci.edu University of California, Irvine 101 The City Drive South Building 23, Room 405 Mail Code: 2675 Orange, CA 92868 Research Interests Hematologic malignancies, both acute and chronic leukemia URL Chao Family Comprehensive Cancer Center Publications See Professorial Series (Adjunct, Clinical X, HS Clinical, In Residence, Ladder Rank) and Professor of Teaching Series If this collaborative, respectful, and inclusive approach speaks to you, I look forward to your selection of UCI Department of Medicine as your training program of choice. We also offer theonly adult hematopoietic stem-cell transplant servicesin Orange County, which means that patients with leukemia, lymphoma and other cancers no longer need to travel long distances for this life-saving treatment. Cancer patients at UCI Health benefit from an individualized treatment plan tailored to their specific condition. The philosophy of our program emphasizes the patient as the best teacher. The EAB reviews the overall strategy and progress and makes specific recommendations to the CFCCC director to improve our goals under our mission. We also offer additional services, such as dietary guidance, pain management, counseling and support groups. Fellowship candidates must have completed a three-year residency program in Internal Medicine that is recognized by ACGME and the ABIM. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston. I am so glad I picked the right Oncologist. Malignant blood diseases such as acute and chronic leukemia, lymphoma, myeloma and other bone marrow disorders often involve a complex treatment plan. Faculty members in these divisions provide clinical services at CHOC Childrens Hospital. Our cancer experts also are available to provide second opinions Medical Education. Fellows participate in weekly didactic lectures as well as academic activities including journal club, M&M, quality improvement, hematology conference, and disease specific lectures. Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. External Advisory Board (EAB) The EAB serves a key role in the CFCCC's planning and evaluation of its three cancer research programs, shared resources and supporting research infrastructure. Professor of Medicine, Biological Chemistry and Public Health. For questions about the application process, go to ERAS online or call 215.966.3940. of complications from the coronavirus because of their compromised immune systems. We are also a Blue Distinction Center for Complex and Rare Cancers. Tiffany Chao, MD. Rapid Fire Lymphoma and Multiple Myeloma Challenge yourself in your knowledge of lymphomas and multiple myeloma Play Now Rapid Fire Leukemia and Myeloproliferative Neoplasm The oncology division provides comprehensive care for children with childhood cancers such leukemia and solid tumors. The division's faculty members serve patients with hematologic and oncologic disorders at the medicalcenter, which is consistently listedamong the top 50 U.S. hospitals by U.S. News & World Report, as well as at the VA Long Beach Healthcare System. Irvine, CA . She is a principal investigator or a co-investigator on many clinical trials evaluating new therapies in genitourinary cancers. The amount of user location information collected and applied has increased, and if these datasets are directly released, attackers may infer other unknown locations through partial background knowledge in their possession. Read More . As a university medical center, we typically have dozens of clinical trials in progress addressing different conditions, including "refractory" cancers that do not respond to standard treatments. Information on specific plans is made available at the time of acceptance. COVID-19 vaccine and protecting your health , UCI Health Chao Family Comprehensive Cancer Center, only adult hematopoietic stem-cell transplant services, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, UCI Health among Americas Best Hospitals for 22nd consecutive year, UCI Health renewed as Orange Countys only federally designated comprehensive cancer center, Gastric cancer patient gets new lease on life, A novel approach to advanced stomach cancer, Beating the odds: Help for advanced gastrointestinal cancers, Eye Care Services | Gavin Herbert Eye Institute, Neonatal Intensive Care Unit Services (NICU), Occupational & Environmental Health Services, Parkinson's Disease and Movement Disorders Program, Pediatric Endocrinology and Diabetes Services, Physical Medicine and Rehabilitation Services, Comprehensive Stroke & Cerebrovascular Center, Susan Samueli Integrative Health Institute, Center for Urological Care | UCI Health Urology Services, Vascular Birthmarks & Malformations Diagnostic and Treatment Center. We also offer theonly adult hematopoietic stem-cell transplant servicesin Orange County, allowing many patients to get this life-saving treatment near home. The hematology division provides diagnostic, therapeutic and consultative care to children with hematologic disorders such as hemophilia, anemia and platelet disorders. At UCI Health, a team of highly experienced hematologists, surgical, medical and radiation oncologists, nurses, dietitians, pathologists and radiologists work together to provide each patient with the best possible care. The NCI designation also means that doctors are focused not only on treating and curing cancer but on cancer prevention and early detection, notes Dr. Richard Van Etten, director of the Chao Center and a professor of medicine in the Division of Hematology/Oncology. We work closely with you and your family to discuss potential treatment options and encourage questions. Fellows receive professional liability coverage for all activities that are part of the hematology/oncology fellowship training program. MyChart patient portal offers a convenient and secure way to manage your healthcare online. Chapter 21. State-of-the-art care is provided including bone marrow transplantation for qualified individuals. Cancers 2023, 15 (5), 1465; https://doi.org/10.3390/cancers15051465 We also have one of the largest early-phase clinical research programs in Southern California, giving patients access to promising experimental medicines through clinical trials. The Hematology/Oncology PRN facilitates the timely dissemination of information related to the clinical practice, research, and teaching of hematology and oncology among its members and serves as a resource for hematology and oncology expertise to others. . . Posted 9:46:56 PM. We are physicians and scientists committed to improving the condition of patients with cancer and blood disorders through state-of-the-art clinical care, research and education. http://www.avensonline.org/fulltextarticles/jun-2380-0585-02-0009.html, Obstructive Jaundice as Initial Presentation of Multiple Myeloma: Case Presentation and Literature Review, https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26221143/, I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib, https://www.sciencedirect.com/science/article/pii/S0169500215000938?via%3Dihub, Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573917/, Patients' preferences for biopsy result notification in an era of electronic messaging methods, https://jamanetwork.com/journals/jamadermatology/fullarticle/2212245, Assessing Bacterial Isolates in Bloodstream Infections and Trend of the Antimicrobial Resistance in the Hematological and Solid Malignancies, http://www.bloodjournal.org/content/126/23/5628/tab-article-info, Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254519/, Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139287/, The case of the missed physical examination: testicular carcinoma presenting as a GI bleed, http://ascopubs.org/doi/abs/10.1200/JCO.2012.45.2680?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551443/, Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593948/, Heart rate decrease during crizotinib treatment and potential correlation to clinical response, Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593561/, Excessive therapeutic response in a case of blastic plasmacytoid dendritic cell neoplasm, Population-based evaluation of adenosquamous carcinoma of the colon and rectum, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330249/, Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy, https://www.futuremedicine.com/doi/full/10.2217/fon.12.25?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&, Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443348/, New mechanistic explanation for the localization of ulcers in the rat duodenum: Role of iron and selective uptake of cysteamine, https://www.sciencedirect.com/science/article/pii/S0003986112002135?via%3Dihub, Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516190/, Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysis, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072650/, Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer, https://insights.ovid.com/pubmed?pmid=21471752, Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202168/, Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140277/, Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017764/, Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles, https://www.spandidos-publications.com/ijmm/26/1/121, Target of rapamycin signaling in leukemia and lymphoma, http://clincancerres.aacrjournals.org/content/16/22/5374.long, Board-certification or board-eligibility in internal medicine, Proof of medical school graduation (original diploma), Proof of passing the three-step United States Medical Licensing Examination (USMLE), U.S. citizenship, permanent residency, or J-1 visa with ECFMG sponsorship. Jason A. Zell, DO, MPH, MSDirector, Fellowship Program, Elizabeth Yi, MPH, MBADivision Administrator Email:elizabeth.yi@uci.edu, Elizabeth AndersonAcademic Programs AnalystEmail: elizabeth.anderson@uci.edu, Christopher G. HaymondBusiness Support Assistant AnalystEmail:chaymond@uci.edu, Elizabeth PearsonClinical Programs Assistant Analyst & Administrative Assistant to Division ChiefEmail: epearson@uci.edu, Christopher SongEducation Programs Assistant AnalystEmail:csong3@uci.edu, University of California, Irvine Irvine, CA 92697. Applicants also should be able to demonstrate their interest in the subspecialties of hematology and oncology. These may include magnetic resonance imaging (MRI), computed tomography (CT) scans, positron emission tomography (PET) scans, endoscopy, X-rays and biopsies. The infusion center at the UCI Health Cancer Center Newport, in particular, was designed to provide a tranquil, healing environment. We also offer theonly adult hematopoietic stem-cell transplant servicesin Orange County, which means that patients with leukemia, lymphoma and other cancers no longer need to travel long distances for this life-saving treatment. View a list of our division faculty members , University of California, Irvine Irvine, CA 92697. Learn more about our research and clinical trials , Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . 2023 The Regents of the University of California. Meanwhile, we continue to provide full services and clinical trial options to our patients while taking exacting precautions for their safety and that of our staff. Welcome to the Division of Hematology/Oncology at UC Irvine's School of Medicine. Uci heme onc fellows irs form 5695 for 2022 how badly do you need to pee gotoquiz. Michelle Clark-Salib fought cancer and delivered a healthy son, COVID-19 vaccine and protecting your health , National Cancer Institute-designated comprehensive cancer center in Orange County, only adult hematopoietic stem-cell transplant services, Our cancer experts also are available to provide second opinions , Hematology-Oncology Services (Leukemia, Lymphoma and Myeloma), Quality OncologyPractice Initiative (QOPI) CertificationProgram, Blue Distinction Center for Complex and Rare Cancers, Learn more about our Blue Distinction Center designation , 53 National Cancer Institute (NCI)-designated comprehensive cancer centers, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Stem cell transplant wards off aggressive lymphoma, Dedicated to cancer research & treatment (video), OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI Health honored for surgical safety and excellence, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, $8 million grant expands access to UCI stem cell clinical trials, Gastric cancer patient gets new lease on life, Riding tall a decade after prostate surgery, A novel approach to advanced stomach cancer, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , Integrate innovative research with the most advanced diagnostics, treatments, rehabilitation and, Offer one of the largest early-phase clinical trials programs in Southern California, giving our patients access to promising therapies before they are available elsewhere. In many cases, this includes chemotherapy following another procedure, such as surgery. For more information, please contact us at ucstudy@hs.uci.edu or 877-827-8839. For cancer treatment to be effective, we believe treatment must be unique and personalized for each patient. Management of Metastatic Colorectal Cancer in the Community-Based Setting. Learn how Michelle Clark-Salib fought cancer and delivered a healthy son, Learn how Alwyn Kong's esophageal cancer was cured without an incision , Learn how a bone marrow transplant has given Sean Ramos his life back , Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . At the UCI Chao Family Comprehensive Cancer Center, we work to prevent, manage, and cure cancer so all people live healthier, longer lives. We are engaged in basic and translational cancer research to better understand cancer and blood diseases and also to use the best, leading-edge clinical approaches for our patients. This button displays the currently selected search type. The three-year program is approved by the Accreditation Council for Graduate Medical Education (ACGME) and is recognized by the American Board of Internal Medicine (ABIM). The infusion center at UC Irvine Health Cancer Center Newport emphasizes tranquility and healing, along with personalized care. Our medical oncologists work closely with UCI Health gynecologic oncologists and colorectal surgeons who perform HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, an advanced treatment for colorectal, gastric, ovarian and other cancers. Patients who were older than 18 years of age and met the criteria of sudden hearing loss without an identifiable etiology were . 15th Annual Hematologic Malignancies Demystified Unraveling the Challenges of Diagnosis and Treatment in Malignant Hematology. May 18-22, 2012 15. Division of Hematology-Oncology, Department of Medicine, University of California, Irvine, CA 92868-3201, USA 7 Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92868-3201, USA * Author to whom correspondence should be addressed. She has a particular interest in benign and malignant hematology, genitourinary malignancies, and cancer prevention. Our medical oncologists are part of a team that treats patients affected by a wide range of cancers and blood disorders at the UCI Health Chao Family Comprehensive Cancer Center, Orange County's only National Cancer Institute-designated comprehensive cancer center. Use MyChart to schedule appointments,request prescription renewals, send messages to your care team and more. The division's fellowship is conducted in concert with the prestigious UCI Health Chao Family Comprehensive Cancer Center, one of 50 U.S. comprehensive cancer centers designated for excellence by the National Cancer Institute. For example, radiation or chemotherapy may be used to shrink a tumor before surgery. Access MyChart Overview Education Bio Locations Medical Services Lung Cancer Services Medical Oncology Services Professor of Clinical Medicine, Hematology/Oncology. bone marrow transplantation, chimeric antigen receptor (CAR) T-cell therapy, natural killer cell therapy. November 25, 2022 The University of California, Irvine (UCI) announces a national search for the Chief, Division of Hematology/Oncology in the Department of Medicine. New York Oncology Hematology P.C ( Site 8000) Albany: New York: 12208: United States: Details Monter Cancer Center ( Site 0054) Lake Success: New York: 11042 . Applications should be submitted as early as possible in order to meet ERAS deadlines for supporting documents and interview schedules. Application WindowOpen November 16, 2022 through Thursday, Nov 16, 2023 at 11:59pm (PacificSee this and similar jobs on LinkedIn. These divisions host a Hematology/Oncology fellowship program. . Frank Meyskens, MD Director Emeritus, Chao Family Comprehensive Cancer Center. Our patients receive the best possible care because, as a comprehensive cancer center, we: Our multidisciplinary team of world-class oncologists, surgeons, radiation oncologists, pathologists, nurses, rehabilitation therapists, pharmacists, social workers and dietitians works together seamlessly to treat cancers of all types and degrees of severity. Our physicians are at the forefront of the latest research and clinical trials and are experts in leading-edge therapies for diseases of the bone marrow offering you only the best care. Select two study versions to compare. These include solid-tumor cancers such as melanoma, colorectal, breast and prostate cancer, as well asmalignancies of the blood, such as leukemia and lymphoma. Appointment as Clinical Staff Investigator within the Chao Family Comprehensive Cancer Center [P30 Cancer Center Support Grant] April 2019- present (one of only two positions at UCI) 16. CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP) UCI School of Medicine . Professor and Chair, Department of Radiation Oncology, Program Co-Leader, Biotechnology, Imaging & Drug Development, Professor, Dermatology and Biological Chemistry, Co-Chair, Protocol Review and Monitoring Committee, Associate Vice Chancellor, Clinical and Translational Science, Director, Institute for Clinical and Translational Sciences, School of Medicine Vice Dean for Clinical Science, Associate Director, Cancer Research Training & Education Coordination, Medical Director for the Stern Center for Cancer Clinical Trials & Research, Professor of Clinical Medicine, Hematology/Oncology, Director Emeritus, Chao Family Comprehensive Cancer Center, Professor of Medicine, Biological Chemistry and Public Health, School of Medicine Vice Dean for Basic Science, Professor, Chemistry and Molecular Biology and Biochemistry, Associate Vice Chancellor, Strategic Initiatives, Office of Research, Program Co-Leader, Systems, Pathways & Targets, Associate Director, Population Science & Cancer Control, Division Chief of Surgical Oncology, Department of Surgery, Co-Director of Center for Cancer Systems Biology, Senior Associate Dean & Associate Vice Chancellor for Cancer, Associate Director, Cancer Health Disparities & Community Engagement, Professor, Epidemiology, School of Public Health, Director, Genomics Research and Technology Hub (GRTH), Professor, Biomedical Engineering & Surgery, 200 S. Manchester Drive, Orange, CA 92868-3217, General Medical Appointments: 714-456-8000, Biotechnology, Imaging & Drug Development, Stern Center for Cancer Clinical Trials and Research, Acknowledgement of Grant and Shared Resources, Anti-Cancer Challenge Pilot Research Projects, CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP), UCI Susan & Henry Samueli College of Health Sciences.